{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:47:50Z","timestamp":1790880470009,"version":"4.1.0"},"reference-count":128,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009602","name":"Howard and Georgeanna Jones Foundation for Reproductive Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009602","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.fertnstert.2024.01.021","type":"journal-article","created":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T11:54:11Z","timestamp":1705665251000},"page":"400-425","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["The impact of fibroid treatments on quality of life and mental health: a systematic review"],"prefix":"10.1016","volume":"121","author":[{"given":"Brooke","family":"Neumann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhuchitra","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Blanck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5969-376X","authenticated-orcid":false,"given":"James H.","family":"Segars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2024.01.021_bib1","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ijgo.2015.04.051","article-title":"Prevalence, morbidity, and current medical management of uterine leiomyomas","volume":"131","author":"Drayer","year":"2015","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib2","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/ajcp\/94.4.435","article-title":"The frequency of uterine leiomyomas","volume":"94","author":"Cramer","year":"1990","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib3","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0029-7844(97)00534-6","article-title":"Variation in the incidence of uterine leiomyoma among premenopausal women by age and race","volume":"90","author":"Marshall","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib4","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1067\/mob.2003.99","article-title":"High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence","volume":"188","author":"Baird","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib5","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1093\/humrep\/deh407","article-title":"Uterine leiomyoma and menstrual cycle characteristics in a population-based cohort study","volume":"19","author":"Marino","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ogc.2005.12.004","article-title":"Epidemiology of myomas","volume":"33","author":"Payson","year":"2006","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib7","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2217\/WHE.09.29","article-title":"Management of uterine fibroids in the patient pursuing assisted reproductive technologies","volume":"5","author":"Ezzati","year":"2009","journal-title":"Womens Health (Lond)"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib8","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ogc.2005.12.002","article-title":"Clinical features of myomas","volume":"33","author":"Bukulmez","year":"2006","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib9","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/01.grf.0000159538.27221.8c","article-title":"Role, epidemiology, and natural history of benign uterine mass lesions","volume":"48","author":"Ryan","year":"2005","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bpobgyn.2017.09.004","article-title":"Epidemiology and risk factors of uterine fibroids","volume":"46","author":"Pavone","year":"2018","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib11","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.bpobgyn.2008.01.008","article-title":"Clinical presentation of fibroids","volume":"22","author":"Gupta","year":"2008","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib12","first-page":"CD010770","article-title":"Selective progesterone receptor modulators (SPRMs) for uterine fibroids","volume":"4","author":"Murji","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib13","doi-asserted-by":"crossref","first-page":"319.e1","DOI":"10.1016\/j.ajog.2013.07.017","article-title":"The impact of uterine leiomyomas: a national survey of affected women","volume":"209","author":"Borah","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1701-2163(15)30338-8","article-title":"The management of uterine leiomyomas","volume":"37","author":"Vilos","year":"2015","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib15","first-page":"229","article-title":"Hysterectomy rates in the United States 1990-1997","volume":"99","author":"Farquhar","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib16","doi-asserted-by":"crossref","first-page":"211.e1","DOI":"10.1016\/j.ajog.2011.12.002","article-title":"The estimated annual cost of uterine leiomyomata in the United States","volume":"206","author":"Cardozo","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib17","first-page":"290","article-title":"The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata","volume":"99","author":"Spies","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib18","article-title":"Assessment of quality of life in patients with cardiovascular disease using the SF-36, MacNew, and EQ-5D-5L Questionnaires","volume":"13","author":"Chatzinikolaou","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib19","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.34067\/KID.0001602022","article-title":"Quality of life in patients with chronic kidney disease managed with or without dialysis: an observational study","volume":"3","author":"So","year":"2022","journal-title":"Kidney360"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib20","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12890-016-0238-9","article-title":"Assessing health-related quality of life in COPD: comparing generic and disease-specific instruments with focus on comorbidities","volume":"16","author":"Wacker","year":"2016","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib21","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.ajog.2020.05.044","article-title":"A systematic review of the psychosocial impact of fibroids before and after treatment","volume":"223","author":"Go","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib22","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1136\/jech-2020-214565","article-title":"Uterine fibroids and incidence of depression, anxiety and self-directed violence: a cohort study","volume":"76","author":"Chiuve","year":"2022","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib23","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jad.2017.02.020","article-title":"Risk of depression in patients with uterine leiomyoma: a nationwide population-based cohort study","volume":"213","author":"Shen","year":"2017","journal-title":"J Affect Disord"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib24","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/01674820400024430","article-title":"The illness experiences of women with fibroids: an exploratory qualitative study","volume":"25","author":"Nicholls","year":"2004","journal-title":"J Psychosom Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib25","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3109\/01674820209074678","article-title":"An exploration of the nature and causes of distress in women attending gynecology outpatient clinics","volume":"23","author":"Glover","year":"2002","journal-title":"J Psychosom Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib26","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11136-013-0442-5","article-title":"Validation of the SF-36 in patients with endometriosis","volume":"23","author":"Stull","year":"2014","journal-title":"Qual Life Res"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib27","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/pubmed\/fdr006","article-title":"Short Form 36 (SF-36) Health Survey Questionnaire: normative data for Wales","volume":"33","author":"Burholt","year":"2011","journal-title":"J Public Health (Oxf)"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib28","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib29","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3390\/healthcare5020022","article-title":"Reliability and validity of the medical outcomes study Short Form-12 Version 2 (SF-12v2) in adults with non-cancer pain","volume":"5","author":"Hayes","year":"2017","journal-title":"Healthcare (Basel)"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib30","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1093\/humrep\/dex057","article-title":"Measuring health-related quality of life in women with endometriosis: comparing the clinimetric properties of the Endometriosis Health Profile-5 (EHP-5) and the EuroQol-5D (EQ-5D)","volume":"32","author":"Aubry","year":"2017","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib31","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1479-828X.2009.01131.x","article-title":"Validation of the WHOQOL-BREF among women following childbirth","volume":"50","author":"Webster","year":"2010","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib32","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/713847100","article-title":"Validation of the Female Sexual Function Index (FSFI) in women with female orgasmic disorder and in women with hypoactive sexual desire disorder","volume":"29","author":"Meston","year":"2003","journal-title":"J Sex Marital Ther"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib33","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1023\/A:1008974420049","article-title":"A health related quality of life measure for use in patients with urge urinary incontinence: a validation study","volume":"8","author":"Lubeck","year":"1999","journal-title":"Qual Life Res"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib34","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s00192-003-1063-2","article-title":"A short form of the Pelvic Organ Prolapse\/Urinary Incontinence Sexual Questionnaire (PISQ-12)","volume":"14","author":"Rogers","year":"2003","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib35","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1093\/humrep\/dez037","article-title":"Validation of the Sexual Activity Questionnaire in women with endometriosis","volume":"34","author":"Oppenheimer","year":"2019","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib36","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1002\/1097-4679(197710)33:4<981::AID-JCLP2270330412>3.0.CO;2-0","article-title":"Confirmation of the dimensional structure of the SCL-90: a study in construct validation","volume":"33","author":"Derogatis","year":"1977","journal-title":"J Clin Psychol"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib37","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/00042192-200007050-00009","article-title":"The brief index of sexual functioning for women (BISF-W): a new scoring algorithm and comparison of normative\u00a0and surgically menopausal populations","volume":"7","author":"Mazer","year":"2000","journal-title":"Menopause"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib38","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"Cochrane Bias Methods Group; Cochrane Statistical Methods Group. The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib39","author":"Wells"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib40","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jvir.2023.09.017","article-title":"An evaluation of ultrasound-guided percutaneous microwave ablation for the treatment of symptomatic uterine fibroids","volume":"35","author":"Ahmadzade","year":"2024","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib41","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1089\/jwh.2022.0133","article-title":"A comparative analysis of health-related quality of life 1 year following myomectomy or uterine artery embolization: findings from the COMPARE-UF registry","volume":"32","author":"Anchan","year":"2023","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib42","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.jmig.2014.02.015","article-title":"Three-year outcome of the Halt trial: a prospective analysis of radiofrequency volumetric thermal ablation of myomas","volume":"21","author":"Berman","year":"2014","journal-title":"J Minim Invas Gynecol"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib43","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10397-015-0915-3","article-title":"The FAST-EU trial: 12-month clinical outcomes of women after intrauterine sonography-guided transcervical radiofrequency ablation of uterine fibroids","volume":"13","author":"Brolmann","year":"2016","journal-title":"Gynecol Surg"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib44","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40349-016-0072-9","article-title":"The safety and effectiveness of volumetric magnetic resonance-guided high-intensity focused ultrasound treatment of symptomatic uterine fibroids: early clinical experience in China","volume":"4","author":"Chen","year":"2016","journal-title":"J Ther Ultrasound"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib45","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/AOG.0000000000003032","article-title":"Ultrasound-guided transcervical ablation of uterine leiomyomas","volume":"133","author":"Chudnoff","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib46","first-page":"1","article-title":"Uterine artery embolisation versus myomectomy for premenopausal women with uterine fibroids wishing to avoid hysterectomy: the FEMME RCT","volume":"26","author":"Daniels","year":"2022","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib47","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1177\/0284185116679458","article-title":"Uterine fibroid embolization with acrylamido polyvinyl microspheres: prospective 12-month clinical and MRI follow-up study","volume":"58","author":"Duvnjak","year":"2017","journal-title":"Acta Radiol"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib48","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejogrb.2022.12.006","article-title":"Uterine myoma position-based radiofrequency ablation (UMP-b RFA): 36 months follow-up clinical outcomes","volume":"281","author":"Fasciani","year":"2023","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib49","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ijgo.2009.11.019","article-title":"Improved quality of life is partly explained by fewer symptoms after treatment of fibroids with mifepristone","volume":"109","author":"Feng","year":"2010","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib50","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1097\/01.AOG.0000243776.23391.7b","article-title":"Effect of mifepristone for symptomatic leiomyomata on quality of life and uterine size: a randomized controlled trial","volume":"108","author":"Fiscella","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib51","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s42155-019-0080-2","article-title":"Impact of uterine contractility on quality of life of women undergoing uterine fibroid embolization","volume":"2","author":"Fornazari","year":"2019","journal-title":"CVIR Endovasc"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib52","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1089\/gyn.2018.0051","article-title":"Long-term clinical outcomes of transcervical radiofrequency ablation of uterine fibroids: the VITALITY study","volume":"35","author":"Garza-Leal","year":"2019","journal-title":"J Gynecol Surg"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib53","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/1477-7525-11-139","article-title":"Radiofrequency volumetric thermal ablation of fibroids: a prospective, clinical analysis of two years\u2019 outcome from the Halt trial","volume":"11","author":"Guido","year":"2013","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib54","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1080\/02656736.2021.1922763","article-title":"Comparison between radiofrequency ablation combined with mifepristone and radiofrequency ablation for large uterine fibroids","volume":"38","author":"Hai","year":"2021","journal-title":"Int J Hyperthermia"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib55","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1080\/02656736.2017.1421323","article-title":"A retrospective study of ultrasound-guided high intensity focussed ultrasound ablation for multiple uterine fibroids in South Africa","volume":"34","author":"He","year":"2018","journal-title":"Int J Hyperthermia"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib56","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/j.ultrasmedbio.2020.02.018","article-title":"Comparison of focused ultrasound surgery and hysteroscopic resection for treatment of submucosal uterine fibroids (FIGO Type 2)","volume":"46","author":"Hu","year":"2020","journal-title":"Ultrasound Med Biol"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib57","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2147\/IJWH.S201912","article-title":"12-month outcomes of the US patient cohort in the Sonata pivotal IDE trial of transcervical ablation of uterine fibroids","volume":"11","author":"Hudgens","year":"2019","journal-title":"Int J Womens Health"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib58","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/13645706.2019.1668417","article-title":"Percutaneous microwave ablation of uterine fibroids: correlation between shrinkage and trend symptoms","volume":"30","author":"Ierardi","year":"2021","journal-title":"Minim Invasive Ther Allied Technol"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib59","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.jmig.2019.07.025","article-title":"Laparoscopic radiofrequency ablation of uterine leiomyomas: clinical outcomes during early adoption into surgical practice","volume":"27","author":"Jacoby","year":"2020","journal-title":"J Minim Invasive Gynecol"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib60","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ejogrb.2022.05.019","article-title":"The effect of transcervical resection of submucous fibroids on menstrual blood loss: a prospective cohort study","volume":"274","author":"Keizer","year":"2022","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib61","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40349-017-0100-4","article-title":"Volumetric magnetic resonance-guided high-intensity focused ultrasound ablation of uterine fibroids through abdominal scars: the impact of a scar patch on therapeutic efficacy and adverse effects","volume":"5","author":"Keserci","year":"2017","journal-title":"J Ther Ultrasound"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib62","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ijgo.2015.10.008","article-title":"Interim analysis of a randomized controlled trial comparing laparoscopic radiofrequency volumetric thermal ablation of uterine fibroids with laparoscopic myomectomy","volume":"133","author":"Kramer","year":"2016","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib63","doi-asserted-by":"crossref","first-page":"174.e1","DOI":"10.1016\/j.ajog.2018.10.032","article-title":"FIRSTT study: randomized controlled trial of uterine artery embolization vs focused ultrasound surgery","volume":"220","author":"Laughlin-Tommaso","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib64","doi-asserted-by":"crossref","first-page":"345.e1","DOI":"10.1016\/j.ajog.2019.09.052","article-title":"Short-term quality of life after myomectomy for uterine fibroids from the COMPARE-UF Fibroid Registry","volume":"222","author":"Laughlin-Tommaso","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib65","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1089\/gyn.2009.0101","article-title":"Radiofrequency thermal ablation of submucosal leiomyoma: a preliminary report on health, symptom, and quality of life outcomes","volume":"26","author":"Lee","year":"2010","journal-title":"J Gynecol Surg"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib66","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ejogrb.2020.11.049","article-title":"Efficacy and safety of transvaginal high-intensity focused ultrasound therapy in women with symptomatic uterine leiomyomas: a clinical trial","volume":"256","author":"Lee","year":"2021","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib67","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1097\/AOG.0b013e3181705d0e","article-title":"CDB-2914 for uterine leiomyomata treatment: a randomized controlled trial","volume":"111","author":"Levens","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib68","first-page":"263","article-title":"Treatment of uterine fibroids by using magnetic resonance-guided focused ultrasound ablation: the initial experience in Taiwan","volume":"34","author":"Lin","year":"2009","journal-title":"J Radiol"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib69","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1097\/AOG.0000000000003211","article-title":"Health-related quality of life with ulipristal acetate for treatment of uterine leiomyomas: a randomized controlled trial","volume":"133","author":"Lukes","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib70","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1089\/gyn.2020.0021","article-title":"Three-year results of the SONATA pivotal trial of transcervical fibroid ablation for symptomatic uterine myomata","volume":"36","author":"Lukes","year":"2020","journal-title":"J Gynecol Surg"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib71","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s13104-017-2558-0","article-title":"One year symptom severity and health-related quality of life changes among black African patients undergoing uterine fibroid embolisation","volume":"10","author":"Mariara","year":"2017","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib72","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ejogrb.2017.12.025","article-title":"Outcome of magnetic resonance-guided focused ultrasound surgery (MRgFUS) for FIGO class 1 fibroids","volume":"221","author":"Mashiach","year":"2018","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.114676","article-title":"Randomized double-blind trial comparing low dose and conventional dose of a modified traditional herbal formula Guizhi Fuling Wan in women with symptomatic uterine fibroids","volume":"283","author":"Meng","year":"2022","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib74","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.fertnstert.2016.06.012","article-title":"Role of ethnicity in treating uterine fibroids with ulipristal acetate","volume":"106","author":"Murji","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib75","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2147\/CEOR.S155038","article-title":"Clinical outcomes and health care utilization pre- and post-laparoscopic radiofrequency ablation of symptomatic fibroids and laparoscopic myomectomy: a randomized trial of uterine-sparing techniques (TRUST) in Canada","volume":"10","author":"Rattray","year":"2018","journal-title":"Clinicoecon Outcomes Res"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib76","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1089\/gyn.2021.0073","article-title":"Durable improvement in generic and fibroid-specific quality of life in women treated with transcervical fibroid ablation with the sonata system after three years","volume":"38","author":"Roy","year":"2022","journal-title":"J Gynecol Surg"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib77","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.jvir.2014.03.009","article-title":"Comparison of polyvinyl alcohol microspheres and tris-acryl gelatin microspheres for uterine fibroid embolization: results of a single-center randomized study","volume":"25","author":"Shlansky-Goldberg","year":"2014","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib78","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s00192-012-2013-7","article-title":"The effect of uterine fibroid embolization on lower urinary tract symptoms","volume":"24","author":"Shveiky","year":"2013","journal-title":"Int Urogynecol J"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib79","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/j.ajog.2004.02.043","article-title":"Patient satisfaction and disease specific quality of life after uterine artery embolization","volume":"190","author":"Smith","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib80","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S1051-0443(99)70235-6","article-title":"Uterine fibroid embolization: measurement of health-related quality of life before and after therapy","volume":"10","author":"Spies","year":"1999","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib81","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1097\/01.AOG.0000188386.53878.49","article-title":"The FIBROID Registry: symptom and quality-of-life status 1 year after therapy","volume":"106","author":"Spies","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib82","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/AOG.0b013e3181ed36b3","article-title":"Outcomes from leiomyoma therapies: comparison with normal controls","volume":"116","author":"Spies","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib83","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/humrep\/dez007","article-title":"Safety and efficacy of the selective progesterone receptor modulator asoprisnil for heavy menstrual bleeding with uterine fibroids: pooled analysis of two 12-month, placebo-controlled, randomized trials","volume":"34","author":"Stewart","year":"2019","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib84","doi-asserted-by":"crossref","first-page":"320.e1","DOI":"10.1016\/j.ajog.2022.11.1278","article-title":"Quality of life with relugolix combination therapy for uterine fibroids: LIBERTY randomized trials","volume":"228","author":"Stewart","year":"2023","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib85","doi-asserted-by":"crossref","DOI":"10.4293\/JSLS.2018.00030","article-title":"Symptoms and health quality after laparoscopic and robotic myomectomy","volume":"22","author":"Takmaz","year":"2018","journal-title":"JSLS"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib86","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/02656736.2018.1479778","article-title":"Ultrasound-guided transvaginal radiofrequency ablation of uterine fibroids assisted by virtual needle tracking system: a preliminary study","volume":"35","author":"Turtulici","year":"2019","journal-title":"Int J Hyperthermia"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib87","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.fertnstert.2019.10.028","article-title":"Comparative effectiveness of hysterectomy versus myomectomy on one-year health-related quality of life in women with uterine fibroids","volume":"113","author":"Wallace","year":"2020","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib88","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s42155-018-0044-y","article-title":"Randomised trial of two embolic agents for uterine artery embolisation for fibroids: gelfoam versus embospheres (RAGE trial)","volume":"2","author":"Yadavali","year":"2019","journal-title":"CVIR Endovas"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib89","article-title":"8Spheres conformal microspheres as embolic agents for symptomatic uterine leiomyoma therapy in uterine artery embolization (UAE): a prospective clinical trial","volume":"102","author":"Zhang","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib90","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1447-0756.2009.01149.x","article-title":"The effect of myomectomy on health-related quality of life of women with myoma uteri","volume":"36","author":"Dilek","year":"2010","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib91","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ejogrb.2010.10.022","article-title":"Prospective comparison of laparoscopic uterine artery occlusion plus myomectomy with classic intrafascial supracervical hysterectomy for symptomatic fibroid treatment: differences in post-operative quality-of-life measures","volume":"155","author":"Liu","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib92","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1080\/09513590.2019.1576618","article-title":"Repeated two cycles of ulipristal acetate treatment improve the quality of life in premenopausal women with heavy menstrual bleeding dependent on uterine myomas, without impairment of bone health","volume":"35","author":"Neri","year":"2019","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib93","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166659","article-title":"Postoperative quality of life and sexual function in premenopausal women undergoing laparoscopic myomectomy for symptomatic fibroids:\u00a0a prospective observational cohort study","volume":"11","author":"Radosa","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib94","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S1051-0443(07)61591-7","article-title":"Initial experience with use of tris-acryl gelatin microspheres for uterine artery embolization for leiomyomata","volume":"12","author":"Spies","year":"2001","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib95","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/uog.7435","article-title":"Magnetic resonance-guided focused ultrasound (MRgFUS) compared with abdominal hysterectomy for treatment of uterine leiomyomas","volume":"34","author":"Taran","year":"2009","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib96","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejogrb.2018.06.027","article-title":"Changes in sexuality during ulipristal acetate treatment in women with symptomatic uterine fibroids","volume":"228","author":"Tuschy","year":"2018","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib97","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.fertnstert.2008.06.007","article-title":"Sexual functioning and psychological well-being after uterine artery embolization in women with symptomatic uterine fibroids","volume":"92","author":"Voogt","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib98","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s00404-013-2775-2","article-title":"Effect of high-intensity focused ultrasound on sexual function in the treatment of uterine fibroids: comparison to conventional myomectomy","volume":"288","author":"Wang","year":"2013","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib99","first-page":"2929","article-title":"Analysis of the effect of laparoscopy and hysteroscopy on ovarian function, immune function and quality of sexual life of patients with hysteromyoma at different ages","volume":"15","author":"Zhang","year":"2018","journal-title":"Oncol Lett"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib100","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/GCO.0b013e328359f10a","article-title":"Review of nonsurgical\/minimally invasive treatments for uterine fibroids","volume":"24","author":"van der Kooij","year":"2012","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib101","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1007\/s43032-022-01120-9","article-title":"A systematic review of minimally invasive approaches to uterine fibroid treatment for improving quality of life and fibroid-associated symptoms","volume":"30","author":"Morris","year":"2023","journal-title":"Reprod Sci"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib102","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1007\/s43032-021-00722-z","article-title":"A systematic review of minimally invasive treatments for uterine fibroid-related bleeding","volume":"29","author":"Zhang","year":"2022","journal-title":"Reprod Sci"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib103","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0016-5085(94)90585-1","article-title":"Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Canadian Crohn's relapse prevention trial study group","volume":"106","author":"Irvine","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib104","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00495-2019","article-title":"Quality of life, tuberculosis and treatment outcome; a case-control and nested cohort study","volume":"56","author":"Datta","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib105","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s12955-021-01876-9","article-title":"Evaluating health related quality of life in outpatients receiving anti-cancer treatment: results from an observational, cross-sectional study","volume":"19","author":"Oh","year":"2021","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib106","first-page":"1255","article-title":"Comparison of SF-36 vitality scale and Fatigue Symptom Inventory in assessing cancer-related fatigue","volume":"19","author":"Brown","year":"2011","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib107","doi-asserted-by":"crossref","first-page":"449","DOI":"10.4048\/jbc.2012.15.4.449","article-title":"Health-related quality of life in breast cancer patients with lymphedema who survived more than one year after surgery","volume":"15","author":"Lee","year":"2012","journal-title":"J Breast Cancer"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib108","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/NMD.0000000000000117","article-title":"Effect of first episode axis I disorders on quality of life","volume":"202","author":"Rubio","year":"2014","journal-title":"J Nerv Ment Dis"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib109","doi-asserted-by":"crossref","first-page":"e445","DOI":"10.4088\/JCP.12m08269","article-title":"Quality of life following remission of mental disorders: Findings from the National Epidemiologic Survey on Alcohol and Related Conditions","volume":"74","author":"Rubio","year":"2013","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib110","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4088\/JCP.09m05094blu","article-title":"Health-related quality of life across the anxiety disorders: Results from the national epidemiologic survey on alcohol and related conditions (NESARC)","volume":"72","author":"Comer","year":"2011","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib111","doi-asserted-by":"crossref","first-page":"E19","DOI":"10.1097\/NCC.0000000000000467","article-title":"Anxiety and the quality of life of children living with parental cancer","volume":"41","author":"Hauken","year":"2018","journal-title":"Cancer Nurs"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib112","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1111\/j.1528-1167.2011.03133.x","article-title":"The impact of depression and anxiety disorder symptoms on the health-related quality of life of children and adolescents with epilepsy","volume":"52","author":"Stevanovic","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib113","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jpsychires.2017.07.022","article-title":"A comprehensive model of predictors of persistence and recurrence in adults with major depression: results from a national 3-year prospective study","volume":"95","author":"Hoertel","year":"2017","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib114","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph182212022","article-title":"Anxiety, depression and quality of life-a systematic review of evidence from longitudinal observational studies","volume":"18","author":"Hohls","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib115","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1089\/jwh.2020.8915","article-title":"Anxiety, depression, and quality of Life after procedural intervention for uterine fibroids","volume":"31","author":"Wallace","year":"2022","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib116","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jpsychores.2014.12.016","article-title":"Beyond the physical: a qualitative assessment of the burden of symptomatic uterine fibroids on women's emotional and psychosocial health","volume":"78","author":"Ghant","year":"2015","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib117","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1742-4755-11-10","article-title":"Uterine leiomyoma: understanding the impact of symptoms on womens' lives","volume":"11","author":"Brito","year":"2014","journal-title":"Reprod Health"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib118","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1023\/B:QURE.0000018472.46236.05","article-title":"IQOLA Project Group. Health-related quality of life associated with chronic conditions in eight countries: results from the international quality of life assessment (IQoLA) project","volume":"13","author":"Alonso","year":"2004","journal-title":"Qual Life Res"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib119","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1051\/ject\/201345008","article-title":"Quality-of-life measures for cardiac surgery practice and research: a review and primer","volume":"45","author":"Tully","year":"2013","journal-title":"J Extra Corpor Technol"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib120","first-page":"1","article-title":"Assessment of quality of life in patients of end stage renal disease on different modalities of treatment","volume":"47","author":"Shrestha","year":"2008","journal-title":"JNMA J Nepal Med Assoc"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib121","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1556\/2060.2021.00017","article-title":"Health-related quality of life of COPD patients aged over 40 years","volume":"108","author":"Fazekas-Pongor","year":"2021","journal-title":"Physiol Int"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib122","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/EDE.0b013e3181567e92","article-title":"Perceived racial discrimination and risk of uterine leiomyomata","volume":"18","author":"Wise","year":"2007","journal-title":"Epidemiology"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib123","doi-asserted-by":"crossref","first-page":"272.e1","DOI":"10.1016\/j.ajog.2012.12.034","article-title":"Lifetime abuse victimization and risk of uterine leiomyomata in black women","volume":"208","author":"Wise","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib124","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0002-9378(95)90077-2","article-title":"Progesterone: a critical role in the pathogenesis of uterine myomas","volume":"172","author":"Rein","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib125","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/ajhb.20057","article-title":"Stress and female reproductive function: a study of daily variations in cortisol, gonadotrophins, and gonadal steroids in a rural mayan population","volume":"16","author":"Nepomnaschy","year":"2004","journal-title":"Am J Hum Biol"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib126","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1210\/jc.2004-2377","article-title":"Hereditary leiomyomatosis associated with bilateral, massive, macronodular adrenocortical disease and atypical Cushing syndrome: a clinical and molecular genetic investigation","volume":"90","author":"Matyakhina","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib127","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s12672-012-0103-0","article-title":"Glucocorticoids regulate gene expression and repress cellular proliferation in human uterine leiomyoma cells","volume":"3","author":"Whirledge","year":"2012","journal-title":"Horm Cancer"},{"key":"10.1016\/j.fertnstert.2024.01.021_bib128","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s12891-016-1083-y","article-title":"Usefulness of the SF-36 Health Survey in screening for depressive and anxiety disorders in rheumatoid arthritis","volume":"17","author":"Matcham","year":"2016","journal-title":"BMC Musculoskelet Disord"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028224000244?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028224000244?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T06:19:00Z","timestamp":1762150740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028224000244"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":128,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0015028224000244"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2024.01.021","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of fibroid treatments on quality of life and mental health: a systematic review","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2024.01.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92024 American Society for Reproductive Medicine, Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}